Viridian Therapeutics, Inc. Share Price
NASDAQ: VRDN | Mid CapViridian Therapeutics, Inc. Stock Performance
Open $22.80 | Prev. Close $22.43 | Circuit Range N/A |
Day Range $22.53 - $23.49 | Year Range $13.18 - $34.25 | Volume 1,34,711 |
Average Traded $23.14 |
Viridian Therapeutics, Inc. Share Price Today
As of 10 August 2026, Viridian Therapeutics, Inc.'s share price is $23.61. The stock opened at $22.80, compared to its previous close of $22.43. During today's trading session, Viridian Therapeutics, Inc.'s share price traded between $22.53 and $23.49, with an average price of $23.01. Over the past 52 weeks, the stock has recorded a high of $34.25 and a low of $13.18. In terms of performance, Viridian Therapeutics, Inc.'s share price has declined by 19.56% over the last six months and is up 28.32% on a year-on-year basis.
Viridian Therapeutics, Inc. Share Price Chart
Viridian Therapeutics, Inc. Stock Fundamentals & Key Indicators
Market Cap $2.00B | PE Ratio (TTM) -7.11 | Dividend Yield N/A |
EPS (TTM) $-3.32 | Revenue (TTM) $70.85M | Return On Equity (TTM) -47.44% |
Profit Margin -483.57% | Debt to Equity 0.10 | Quarterly Earnings Growth YoY 54.88% |
Viridian Therapeutics, Inc. Quarterly Profit & Loss
All figures in USD
Viridian Therapeutics, Inc. Annual Profit & Loss
All figures in USD
About Viridian Therapeutics, Inc.
Viridian Therapeutics, Inc. engages in discovering, developing, and commercializing treatments for serious and rare diseases. The company's product pipeline includes veligrotug, a monoclonal antibody targeting insulin-like growth factor-1 receptor that is in Phase 3 clinical trial for the treatment of thyroid eye disease (TED); and VRDN-003, a next generation IGF-1R monoclonal antibodies targeting IGF-1R and engineered of half-life extension technology, which is in Phase 3 clinical trial for the treatment of TED. It also develops portfolio of engineered anti-neonatal Fc receptor inhibitors, such as VRDN-006 and VRDN-008 for autoimmune disease. The company was formerly known as Miragen Therapeutics, Inc. and changed its name to Viridian Therapeutics, Inc. in January 2021.Viridian Therapeutics, Inc. was founded in 2010 and is headquartered in Waltham, Massachusetts.
Viridian Therapeutics, Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Aug 2026 | $18.68 | $23.60 | +24.67% |
Jul 2026 | $18.95 | $18.93 | +2.94% |
Jun 2026 | $17.54 | $18.39 | +4.34% |
May 2026 | $13.58 | $17.63 | +30.99% |
Apr 2026 | $19.72 | $13.46 | -31.16% |
Mar 2026 | $28.76 | $19.55 | -33.41% |
Feb 2026 | $33.23 | $29.35 | -11.07% |
Jan 2026 | $31.23 | $33.01 | +6.02% |
Dec 2025 | $31.91 | $31.13 | -2.57% |
Nov 2025 | $23.78 | $31.95 | +35.27% |
Oct 2025 | $21.48 | $23.62 | +9.40% |
Sep 2025 | $18.89 | $21.59 | +17.34% |
VRDN Share Price FAQs
What is Viridian Therapeutics, Inc. share price today?
What is the 52 week high and 52 week low of Viridian Therapeutics, Inc. stock?
What is VRDN's market capitalisation today?
What is VRDN's net income for the last quarter?
What is the 5 year returns of VRDN?
What is the high & low stock price of VRDN today?
Can I buy VRDN shares in India?